Logan Health is proud to spotlight our virtual guest speakers for the symposium.
Andrew Sas, MD, PhD
Assistant Professor of Neurology
Ohio State University
Dr. Sas is an MD PhD clinician scientist in the Department of Neurology at The Ohio State University. Dr. Sas completed his MD and PhD at the Medical University of South Carolina with a research focus in neuroimmunology. He completed his residency in neurology at the University of Michigan where he was chief resident in his final year. Dr. Sas then completed a clinical fellowship in sports neurology and traumatic brain injury at the University of Michigan, where he was a sideline physician for Eastern Michigan University and a neurological consultant for University of Michigan Athletics. At Ohio State University, Dr. Sas sees traumatic brain injury patients in the clinic and continues to shape concussion care as a neurological consultant for Ohio State Sports Medicine and Athletics. Dr. Sas maintains an active laboratory using animal models to explore use of the immune system to promote recovery after traumatic nervous system injury. His focus is on the recruitment and enhancement of neuroprotective and regenerative myeloid cells after neuronal injury that can stimulate axon regeneration and recovery from trauma.
Chelsea Kane, PsyD
Clinical Assistant Professor, Department of Physical Medicine and Rehabilitation
Ohio State University
Chelsea Kane, PsyD, ABPP is an Assistant Professor in the Department of Physical Medicine and Rehabilitation at Ohio State University. She earned her doctorate from the University of Indianapolis and completed residency at the University of Miami-Jackson Memorial Hospital (Miami, FL). She completed her post-doctoral fellowship in rehabilitation and neuropsychology at Ohio State University. She has been on faculty at OSU since fall 2017. Her clinical work spans inpatient, critical care, and outpatient settings with outpatient work being exclusively neuropsychological assessment. Dr. Kane has research experience consulting on and managing projects across clinical populations including chronic pain, traumatic brain injury, stroke, and spinal cord injury. She currently manages “Physiological Markers of Early Recovery following TBI”; this study is assessing how TBI affects autonomic dysregulation, metabolic functioning and aims to discern how hyper-inflammation may be associated with recovery trajectory, cognitive and executive functioning, emotion regulation, and community participation. The study aims to characterize longitudinal changes in physiological markers that may foreshadow later decline, and evaluate relationships with cognitive and psychosocial functioning. Finally, Dr. Kane is passionate about knowledge translation and communication of research findings to public and stakeholder audiences.